National Commission on Scleroderma and Fibrotic Diseases Act of 2019
United States116th CongressS-2477Senate
Updated: Sep 12, 2019
Summary
National Commission on Scleroderma and Fibrotic Diseases Act of 2019 This bill temporarily establishes a National Commission on Fibrotic Diseases within the National Institutes of Health that must recommend improvements regarding fibrosis and fibrotic disease research.
Bill texts
All available records shown.
Timeline
Latest companion bill action
HR-3446: National Commission on Scleroderma and Fibrotic Diseases Act of 2019Referred to the Subcommittee on Health.
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Senate
Introduced in Senate
All available records shown.